# Notice of Intent to Sole Source - ECig Intelligence Database Subscription Canonical: https://abierto.us/opportunities/75f40124q00404 - Solicitation number: 75F40124Q00404 - Notice type: Combined synopsis and solicitation - Status: Closed. Deadline was July 8, 2024 at 2:00 PM EDT - Department: Department of Health and Human Services - Agency: Food and Drug Administration - Contracting office: FDA Office of Acq Grant SVCS (75F401) - NAICS: 541519 Other Computer Related Services - Product or service code: R612 Information Retrieval - Set-aside: 8(a) sole source - Place of performance: Beltsville, Maryland - County: Prince George's County (FIPS 24033). https://abierto.us/counties/prince-george-s-county-md-24033 - City: Beltsville. https://abierto.us/cities/beltsville-md-2406400 - First posted: July 2, 2024 - Last posted: July 2, 2024 - SAM.gov: https://sam.gov/workspace/contract/opp/cae95543c81d4f9c9e9304cb563af048/view ## Description Notice of Intent to Sole Source The Food and Drug Administration intends to make a sole source award for a subscription to Ecig intelligence, a comprehensive source known for Electronic Nicotine Delivery System (ENDS) market data. The FDAs/Center for Tobacco Products requires this data to be able to measure and compare incidence and usage rates, market size, product form adoption, online and offline pricing, distribution channels, domestic and foreign product and marketing regulation, taxes, and points of contact. Effective regulation necessitates a full knowledge of the history and status of these factors and how they affect the market domestically and internationally. ECigIntelligence is the only source for the comprehensive data needed. We intend to make a sole source award for this subscription to: ECigIntelligence 5 St. John’s Lane London ECIM 4BH In accordance with FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement within five (5) days after the publication of this synopsis which shall be considered by the agency. Responses received after 5 days or without the required information may not be considered. For information concerning this acquisition contact: Nakita Putty Contract Specialist Nakita.Putty@fda.hhs.gov A determination by the Government not to compete because of information received is solely within the discretion of the Government. Information received will normally be considered solely for determining whether to conduct a competitive procurement. FAR Clauses Incorporated by Reference. 52.203-19 – Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements (Jan 2017) 52.204-23 – Prohibition on Contracting for Hardware, Software and Services Developed or Provided by Kaspersky Lab and Other Covered Entities (Nov 2021) 52.204-25 – Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021) 52.222-26 Equal Opportunity (Sept 2016) 52.204-27 Prohibition on a ByteDance Covered Application (Jun 2023) 52.227-14 Rights in Data – General (May 2014) 52.227-19 – Commercial Computer Software License (Dec 2007) 52.232-39 – Unenforceability of Unauthorized Obligations (Jun 2013) 52.232-40 – Providing Accelerated Payment to Small Business Subcontractors (Mar 2023) FAR Provisions Incorporated by Reference 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements—Representation (Jan 2017) 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021) 52.204-26 Covered Telecommunications Equipment or Services-Representation (Oct 2020) 52.212-1 Instructions to Offerors—Commercial Products and Commercial Services (Sep 2023) ## Publications - July 2, 2024: Combined synopsis and solicitation, due July 8, 2024 at 2:00 PM EDT. Notice cae95543c81d4f9c9e9304cb563af048. https://sam.gov/workspace/contract/opp/cae95543c81d4f9c9e9304cb563af048/view ## Points of contact - Nakita Putty, Nakita.Putty@fda.hhs.gov, 3017967104 --- Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75f40124q00404.